Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 2/2019

01-02-2019 | Pictorial essay

Imaging features related with prognosis of hepatocellular carcinoma

Authors: Chansik An, Myeong-Jin Kim

Published in: Abdominal Radiology | Issue 2/2019

Login to get access

Abstract

We discuss various imaging features that have been reported to be associated with the prognosis of hepatocellular carcinoma (HCC) but not included in the current staging systems: findings related with microvascular invasion, tumor encapsulation, intratumoral fat, presence of satellite nodules, peritumoral hypointensity on hepatobiliary phase images of gadoxetic-acid enhanced MRI, restricted diffusion, and irregular rim-like hyperenhancement. Current evidence suggests that larger (> 2 cm) tumor size, presence of satellite nodules, presence of irregular rim-like hyperenhancement of a tumor, peritumoral parenchymal enhancement in the arterial phase, and peritumoral hypointensity observed on hepatobiliary phase images are independent imaging features to portend a worse prognosis in patients with hepatocellular carcinoma.
Literature
1.
Sia D, Villanueva A, Friedman SL, Llovet JM (2017) Liver cancer cell of origin, molecular class, and effects on patient prognosis. Gastroenterology 152:745–761CrossRefPubMed
2.
Kim H, Park YN (2014) Hepatocellular carcinomas expressing ‘stemness’-related markers: clinicopathological characteristics. Dig Dis 32:778–785CrossRefPubMed
3.
Walther Z, Jain D (2011) Molecular pathology of hepatic neoplasms: classification and clinical significance. Patholog Res Int 2011:403929PubMedPubMedCentral
4.
Elizabeth M, Brunt VP, Sempoux Christine, Theise ND (2015) Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress. Hepat Oncol 2:330–336
5.
Fan L, Mac MT, Frishberg DP, et al. (2010) Interobserver and intraobserver variability in evaluating vascular invasion in hepatocellular carcinoma. J Gastroenterol Hepatol 25:1556–1561CrossRefPubMed
6.
Pirisi M, Leutner M, Pinato DJ, et al. (2010) Reliability and reproducibility of the edmondson grading of hepatocellular carcinoma using paired core biopsy and surgical resection specimens. Arch Pathol Lab Med 134:1818–1822PubMed
7.
Pawlik TM, Gleisner AL, Anders RA, et al. (2007) Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility. Ann Surg 245:435–442CrossRefPubMedPubMedCentral
8.
Bruix J, Sherman M, American Association for the Study of Liver Diseases (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022CrossRefPubMedPubMedCentral
9.
European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943CrossRef
10.
Kudo M, Matsui O, Izumi N, et al. (2014) Surveillance and diagnostic algorithm for hepatocellular carcinoma proposed by the Liver Cancer Study Group of Japan: 2014 update. Oncology 87(Suppl 1):7–21CrossRefPubMed
11.
Lee JM, Park JW, Choi BI (2014) 2014 KLCSG-NCC Korea Practice Guidelines for the management of hepatocellular carcinoma: HCC diagnostic algorithm. Dig Dis 32:764–777CrossRefPubMed
12.
Omata M, Lesmana LA, Tateishi R, et al. (2010) Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 4:439–474CrossRefPubMedPubMedCentral
13.
Bruix J, Reig M, Sherman M (2016) Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology 150:835–853CrossRefPubMed
14.
15.
Chandarana H, Robinson E, Hajdu CH, et al. (2011) Microvascular invasion in hepatocellular carcinoma: is it predictable with pretransplant MRI? AJR Am J Roentgenol 196:1083–1089CrossRefPubMed
16.
Eguchi S, Takatsuki M, Hidaka M, et al. (2010) Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection. World J Surg 34:1034–1038CrossRefPubMed
17.
Kaibori M, Ishizaki M, Matsui K, Kwon AH (2010) Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma. J Surg Oncol 102:462–468CrossRefPubMed
18.
McHugh PP, Gilbert J, Vera S, et al. (2010) Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma. HPB (Oxford) 12:56–61CrossRef
19.
Ariizumi S, Kitagawa K, Kotera Y, et al. (2011) A non-smooth tumor margin in the hepatobiliary phase of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and early recurrence after hepatectomy in patients with hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 18:575–585CrossRefPubMed
20.
Chou CT, Chen RC, Lin WC, et al. (2014) Prediction of microvascular invasion of hepatocellular carcinoma: preoperative CT and histopathologic correlation. AJR Am J Roentgenol 203:W253–W259CrossRefPubMed
21.
Lim JH, Choi D, Park CK, Lee WJ, Lim HK (2006) Encapsulated hepatocellular carcinoma: CT-pathologic correlations. Eur Radiol 16:2326–2333CrossRefPubMed
22.
Kim H, Park MS, Choi JY, et al. (2009) Can microvessel invasion of hepatocellular carcinoma be predicted by pre-operative MRI? Eur Radiol 19:1744–1751CrossRefPubMed
23.
Nishie A, Yoshimitsu K, Asayama Y, et al. (2008) Radiologic detectability of minute portal venous invasion in hepatocellular carcinoma. AJR Am J Roentgenol 190:81–87CrossRefPubMed
24.
Kim KA, Kim MJ, Jeon HM, et al. (2012) Prediction of microvascular invasion of hepatocellular carcinoma: usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images. J Magn Reson Imaging 35:629–634CrossRefPubMed
25.
Suh YJ, Kim MJ, Choi JY, Park MS, Kim KW (2012) Preoperative prediction of the microvascular invasion of hepatocellular carcinoma with diffusion-weighted imaging. Liver Transpl 18:1171–1178CrossRefPubMed
26.
Xu P, Zeng M, Liu K, et al. (2014) Microvascular invasion in small hepatocellular carcinoma: is it predictable with preoperative diffusion-weighted imaging? J Gastroenterol Hepatol 29:330–336CrossRefPubMed
27.
Wang WT, Yang L, Yang ZX, et al. (2018) Assessment of microvascular invasion of hepatocellular carcinoma with diffusion kurtosis imaging. Radiology 286:571–580CrossRefPubMed
28.
Segal E, Sirlin CB, Ooi C, et al. (2007) Decoding global gene expression programs in liver cancer by noninvasive imaging. Nat Biotechnol 25:675–680CrossRefPubMed
29.
Kim JY, Kim MJ, Kim KA, Jeong HT, Park YN (2012) Hyperintense HCC on hepatobiliary phase images of gadoxetic acid-enhanced MRI: correlation with clinical and pathological features. Eur J Radiol 81:3877–3882CrossRefPubMed
30.
Banerjee S, Wang DS, Kim HJ, et al. (2015) A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma. Hepatology 62:792–800CrossRefPubMedPubMedCentral
31.
Renzulli M, Brocchi S, Cucchetti A, et al. (2016) Can current preoperative imaging be used to detect microvascular invasion of hepatocellular carcinoma? Radiology 279:432–442CrossRefPubMed
32.
Kim MJ, Lee M, Choi JY, Park YN (2012) Imaging features of small hepatocellular carcinomas with microvascular invasion on gadoxetic acid-enhanced MR imaging. Eur J Radiol 81:2507–2512CrossRefPubMed
33.
An C, Choi GH, Lee HS, Kim MJ (2012) Assessment of preoperative magnetic resonance imaging staging in patients with hepatocellular carcinoma undergoing resection compared with the seventh American Joint Committee on Cancer System. Invest Radiol 47:634–641CrossRefPubMed
34.
Shindoh J, Andreou A, Aloia TA, et al. (2013) Microvascular invasion does not predict long-term survival in hepatocellular carcinoma up to 2 cm: reappraisal of the staging system for solitary tumors. Ann Surg Oncol 20:1223–1229CrossRefPubMed
35.
American Joint Committee on Cancer (2017) AJCC cancer staging manual, 8th edn. New York: Springer
36.
Chen BB, Hsu CY, Yu CW, et al. (2016) Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy. Radiology 281:454–464CrossRefPubMed
37.
Gao SY, Tang L, Cui Y, et al. (2016) Tumor angiogenesis-related parameters in multi-phase enhanced CT correlated with outcomes of hepatocellular carcinoma patients after radical hepatectomy. Eur J Surg Oncol 42:538–544CrossRefPubMed
38.
Kawamura Y, Ikeda K, Seko Y, et al. (2011) Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation. AJR Am J Roentgenol 197:W665–W673CrossRefPubMed
39.
Kierans AS, Leonardou P, Hayashi P, et al. (2010) MRI findings of rapidly progressive hepatocellular carcinoma. Magn Reson Imaging 28:790–796CrossRefPubMed
40.
Kitao A, Matsui O, Yoneda N, et al. (2012) Hypervascular hepatocellular carcinoma: correlation between biologic features and signal intensity on gadoxetic acid-enhanced MR images. Radiology 265:780–789CrossRefPubMedPubMedCentral
41.
Murakata A, Tanaka S, Mogushi K, et al. (2011) Gene expression signature of the gross morphology in hepatocellular carcinoma. Ann Surg 253:94–100CrossRefPubMed
42.
Nakanishi M, Chuma M, Hige S, et al. (2012) Relationship between diffusion-weighted magnetic resonance imaging and histological tumor grading of hepatocellular carcinoma. Ann Surg Oncol 19:1302–1309CrossRefPubMed
43.
Shimizu R, Tamai H, Mori Y, et al. (2016) The arterial tumor enhancement pattern on contrast-enhanced computed tomography is associated with primary cancer death after radiofrequency ablation for small hepatocellular carcinoma. Hepatol Int 10:328–339CrossRefPubMed
44.
Siripongsakun S, Lee JK, Raman SS, et al. (2012) MRI detection of intratumoral fat in hepatocellular carcinoma: potential biomarker for a more favorable prognosis. AJR Am J Roentgenol 199:1018–1025CrossRefPubMed
45.
Wu TH, Yu MC, Chen TC, et al. (2012) Encapsulation is a significant prognostic factor for better outcome in large hepatocellular carcinoma. J Surg Oncol 105:85–90CrossRefPubMed
46.
Xu L, Peng ZW, Chen MS, et al. (2015) Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization. J Hepatol 63:122–130CrossRefPubMed
47.
Yamashita T, Kitao A, Matsui O, et al. (2014) Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma. Hepatology 60:1674–1685CrossRefPubMedPubMedCentral
48.
Ng IO, Lai EC, Ng MM, Fan ST (1992) Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases. Cancer 70:45–49CrossRefPubMed
49.
Kang TW, Rhim H, Lee J, et al. (2016) Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma. Eur Radiol 26:3437–3446CrossRefPubMed
50.
Kim BK, Kim KA, An C, et al. (2015) Prognostic role of magnetic resonance imaging vs. computed tomography for hepatocellular carcinoma undergoing chemoembolization. Liver Int 35:1722–1730CrossRefPubMed
51.
Jeong HT, Kim MJ, Kim YE, et al. (2012) MRI features of hepatocellular carcinoma expressing progenitor cell markers. Liver Int 32:430–440PubMed
52.
Choi SY, Kim SH, Park CK, et al. (2018) Imaging features of gadoxetic acid-enhanced and diffusion-weighted MR imaging for identifying cytokeratin 19-positive hepatocellular carcinoma: a retrospective observational study. Radiology 286:897–908CrossRefPubMed
53.
54.
An C, Kim DW, Park YN, et al. (2015) Single hepatocellular carcinoma: preoperative MR imaging to predict early recurrence after curative resection. Radiology 276:433–443CrossRefPubMed
55.
Lee S, Kim SH, Lee JE, Sinn DH, Park CK (2017) Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma. J Hepatol 67:526–534CrossRefPubMed
56.
57.
Li M, Xin Y, Fu S, et al. (2016) Corona enhancement and mosaic architecture for prognosis and selection between of liver resection versus transcatheter arterial chemoembolization in single hepatocellular carcinomas > 5 cm without extrahepatic metastases: an imaging-based retrospective study. Medicine 95:e2458CrossRefPubMedPubMedCentral
58.
Sakon M, Nagano H, Nakamori S, et al. (2002) Intrahepatic recurrences of hepatocellular carcinoma after hepatectomy: analysis based on tumor hemodynamics. Arch Surg 137:94–99CrossRefPubMed
Metadata
Title
Imaging features related with prognosis of hepatocellular carcinoma
Authors
Chansik An
Myeong-Jin Kim
Publication date
01-02-2019
Publisher
Springer US
Published in
Abdominal Radiology / Issue 2/2019
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-018-1758-y

Other articles of this Issue 2/2019

Abdominal Radiology 2/2019 Go to the issue

OriginalPaper

Comparison of complications rates between multiparametric magnetic resonance imaging-transrectal ultrasound (TRUS) fusion and systematic TRUS prostatic biopsies

OriginalPaper

LI-RADS for CT diagnosis of hepatocellular carcinoma: performance of major and ancillary features

Pictorial essay

Pearls and pitfalls of response evaluation criteria in solid tumors (RECIST) v1.1 non-target lesion assessment

OriginalPaper

Evaluation of acoustic radiation force impulse (ARFI) elastography as non-invasive diagnostic tool in living donor liver transplantation

Pictorial essay

Approach to pediatric renal tumors: an imaging review

OriginalPaper

Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits